Attached files

file filename
10-K - ANNUAL REPORT - Ainos, Inc.amar_10k.htm
EX-33.1 - CERTIFICATION - Ainos, Inc.amar_ex331.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Ainos, Inc.amar_ex311.htm
EX-10.1(J) - EXTENSION OF THE CONSULTING AGREEMENT AND PRE-EXISTING WARRANT CERTIFICATE BETWE - Ainos, Inc.amar_ex101j.htm
EX-10.1(I) - SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE, EFFECTIVE 12/24/20 - Ainos, Inc.amar_ex101i.htm
EX-10.1(H) - EMPLOYMENT AGREEMENT BETWEEN COMPANY AND BERNARD COHEN DATED 12/31/20 AND EFFECT - Ainos, Inc.amar_ex101h.htm
EX-10.1(G) - AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT BETWEEN COMPANY AND STEPHEN T. CHEN, PH. - Ainos, Inc.amar_101g.htm
EX-10.1(F) - EMPLOYMENT AGREEMENT BETWEEN COMPANY AND STEPHEN T. CHEN, PH.D. DATED 12/31/20 A - Ainos, Inc.amar_ex101f.htm
 
  Exhibit 99.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of Amarillo Biosciences, Inc. on Form 10-K for the period ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
 
1.            
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.            
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
 
 
Date: March 30, 2021
 
       /s/ Stephen T. Chen
 
 
Stephen T. Chen, Chairman of the Board,
Chief Executive Officer and Chief Financial Officer
 
 
 
F-6